Harbin Medisan Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of September 2025: 2.59%

Harbin Medisan Pharmaceutical Co Ltd asset resilience ratio. Harbin Medisan Pharmaceutical Co Ltd (002900) has an Asset Resilience Ratio of 2.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002900 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥93.31 Million

≈ $13.65 Million USD Cash + Short-term Investments

Total Assets

CN¥3.61 Billion

≈ $528.15 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Harbin Medisan Pharmaceutical Co Ltd (2018–2024)

Asset resilience ratio of Harbin Medisan Pharmaceutical Co Ltd from 2018 to 2024. This chart shows how Harbin Medisan Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Harbin Medisan Pharmaceutical Co Ltd (002900) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Harbin Medisan Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Harbin Medisan Pharmaceutical Co Ltd's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥93.31 Million	2.59%
Total Liquid Assets	CN¥93.31 Million	2.59%

Asset Resilience Insights

Limited Liquidity: Harbin Medisan Pharmaceutical Co Ltd maintains only 2.59% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Harbin Medisan Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Harbin Medisan Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Harbin Medisan Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2018–2024)

Harbin Medisan Pharmaceutical Co Ltd asset resilience ratio by year from 2018 to 2024. The table below shows the annual Asset Resilience Ratio data for Harbin Medisan Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.27%	CN¥48.08 Million ≈ $7.04 Million	CN¥3.80 Billion ≈ $556.13 Million	-0.41pp
2023-12-31	1.68%	CN¥57.75 Million ≈ $8.45 Million	CN¥3.44 Billion ≈ $503.82 Million	-1.11pp
2022-12-31	2.78%	CN¥91.25 Million ≈ $13.35 Million	CN¥3.28 Billion ≈ $479.50 Million	-16.19pp
2021-12-31	18.97%	CN¥581.68 Million ≈ $85.12 Million	CN¥3.07 Billion ≈ $448.58 Million	+4.44pp
2020-12-31	14.53%	CN¥360.79 Million ≈ $52.80 Million	CN¥2.48 Billion ≈ $363.31 Million	-11.54pp
2019-12-31	26.07%	CN¥696.72 Million ≈ $101.95 Million	CN¥2.67 Billion ≈ $391.02 Million	+21.90pp
2018-12-31	4.17%	CN¥104.91 Million ≈ $15.35 Million	CN¥2.51 Billion ≈ $367.81 Million	--

pp = percentage points

About Harbin Medisan Pharmaceutical Co Ltd

SHE:002900 China Drug Manufacturers - Specialty & Generic

Market Cap

$466.17 Million

CN¥3.19 Billion CNY

Market Cap Rank

#12324 Global

#3549 in China

Share Price

CN¥10.07

Change (1 day)

+1.41%

52-Week Range

CN¥9.18 - CN¥15.63

All Time High

CN¥32.63